Psychological Factors in Chemical Warfare and Terrorism*z

Chemical Warfare Agents: Toxicity at Low Levels

Volumn , Issue , 2000, Pages 393-407

  Romano, James A ^a   King, James A ^b  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b Information Analysis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85152306270     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041576-16     Document Type: Chapter

References (68)

1. Chandler, R.W. and Backschies, J.R., The New Face of War, AMCODA Press, McLean, VA, 1998.
2. Chandler, R.W. and Trees, R.J., Tomorrow’s War, Today’s Decisions, AMCODA Press, McLean, VA, 1996.
3. Presidential Decision Directive #62-Combating Terrorism, Office of the Press Secretary, the White House, Washington, DC, 1998.
4. Presidential Decision Directive #63-Critical Infrastructure Protection, Office of the Press Secretary, the White House, Washington, DC, 1998.
5. National Domestic Preparedness Office, Department of Justice, Federal Bureau of Investigation, URL http://www.ndpo.com.
6. Sciuto, A.M., Disruption of gas exchange in mice following exposure to the chemical threat agent phosgene, J. Mil. Psychol., in press.
7. Moore, S. and Gates, M., Hydrogen cyanide and cyanogen chloride, in Chemical Warfare Agents and Related Chemical Problems. Parts I and II, Summary technical report of Division 9, National Defense Research Committee, vol. 1., Washington, DC, 2, 7, 1946.
8. Mills, E.G., Gunasekar, P.G., Li, I., Borowitz, J.L., and Isom, G.E., Differential susceptibility of brain areas to cyanide involves different modes of cell death, Toxicol. Appl. Pharmacol., 156, 6, 1999.
9. Utti, R.J., Jajput, A.H., Ashenhurst, E.M., and Rozdilksky, B., Cyanide-induced Parkinsonism: A clinicopathologic report, Neurology, 35, 921, 1985.
10. Baskin, S.I. and Brewer, T., Cyanide poisoning, in Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R. and Bellamy R.F., Eds., Office of the Surgeon General, Department of the Army, Washington, DC, 1997, chap. 10.
11. Kanthasamy, A.G., Borowitz, J.L., Pavlokovik, G., and Isom, G.E., Dopaminergic neurotoxicity of cyanide: Neurochemical, histological, and behavioral characterization, Toxicol. Appl. Pharmacol., 126, 156, 1994.
12. Vedder, E.B., The Vesicants, in: The Medical Aspects of Chemical Warfare, Vedder, E.B., Ed., Williams and Wilkins Co., Baltimore, 1925.
13. Sidell, F.R. and Hurst, C.G., Long-term health effects of nerve agents and mustard, in Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R. and Bellamy, R.F., Eds., Office of the Surgeon General, Department of the Army, Washington, DC, 1997, chap. 8.
14. Willems, J., Clinical management of mustard gas casualties, Ann. Med. Mil. Belgicae, (Supplement)1-6, 1989.
15. Sidell, F.R. and Hurst, C.G., in Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R. and Bellamy, R.F., Eds., Office of the Surgeon General, Department of the Army, Washington, DC, 1997, chap. 7.
16. Eisenmenger, W., Drasch, G., von Clarsmann, M., Kietschner, E., and Roider G., Clinical and morphological findings on mustard gas [bis(2-chloroethyl) sulfide] poisoning, J. Foren. Sci., 36, 1688, 1991.
17. Lohs, K., Delayed Toxic Effects of Chemical Warfare Agents, Stockholm: Almquist and Wiltsell, SIPRI Monograph, 1975.
18. Balali-Mood, M., First reports of delayed toxic effects of yperite poisoning in Iranian fighters, Proc. Int. Assoc. Foren. Toxicol., 1986.
19. McDonough, J.H., Performance impacts of nerve agents and their pharmacologic countermeasures, J. Mil. Psychol., in press.
20. Longo, V.G., Behavioral and electroencephalographic effects of atropine and related compounds, Pharmacol. Rev., 18, 965, 1996.
21. Karczmar, A., Acute and long-lasting concentrations of organophosphorus agents, Fund. Appl. Toxicol., 4(2), 51, 1984.
22. McDonough, J.H. and Shih, T.A., Neuropharmacological mechanisms of nerve agentinduced seizures and neuropathology, Neurosci. Biobehav. Rev., 21(5), 559, 1997.
23. McDonough, J.H., Smith, R.F., and Smith, C.D., Behavioral correlates of soman-induced neuropathology: Deficits in DRL acquisition, Neurobehav. Toxicol. Teratol., 8, 179, 1986.
24. Raffaele, K., Hughey, D., Wenk, G., Olton, D., Modrow, H., and McDonough, J., Longterm behavioral changes in rats following organophosphonate exposure, Pharmacol. Biochem. Behav., 27, 407, 1987.
25. Castro, C.A., Gresham, V.C., Finger, A.V., Maxwell, D.M., Solana, R.P., Lenz, D.E., and Broomfield, C.A., Behavioral decrements in rhesus monkeys trained on a serial probe recognition task despite protection again soman lethality by butyrylcholinesterase, Neurotoxicol. Teratol., 16, 145, 1994.
26. Romano, J.A., Penetar, D.M., and King, J.M., A comparison of physostigmine and soman using taste aversion and nociception, Neurobehav. Toxicol. Teratol., 7, 243, 1985.
27. Romano, J.A. and Landauer, M.R., Effects of the organophosphorus o-ethyl-n-dimethyl phosphorametocyanidate (tabun) on flavor aversions, locomotor activity, and rotarod performance, Fund. Appl. Toxicol., 6, 62, 1986.
28. Blick, D.W., Murphy, M.R., Brown, G.C., Yochmowitz, M.G., Fanton, J.W., and Hartgraves, S.L., Acute behavioral toxicity of pyridostigmine or soman in primates, Toxicol. Appl. Pharmacol., 126, 311, 1994.
29. Grob, D. and Harvey, A.M., Effects in man of the anticholinesterase compound sarin isopropyl methyl-phosphonofluoridate, J. Clin. Invest., 37, 350, 368, 1958.
30. Romano, J.A., Terry, M., Murrow, M., and Mays, M., Protection from soman-induced lethality and incapacitation by atropine and 2-PAM chloride in the guinea pig, Cavia porcellus, Drug Chem. Toxicol., 14, 21, 1991.
31. Annual Report to Congress: Federally Sponsored Research on Gulf War Veterans’ Illnesses for 1977, Department of Veterans Affairs, URL http://www.va.gov/resdev/ pgrpt97.htm.
32. Savage, E., Keefe, T., Mounce, L., Heaton, R., Lewis, J., and Burcar, P., Chronic sequelae of acute organophosphate pesticide poisoning, Arch. Environ. Health, 43, 38, 1990.
33. Steenland, K., Jenkins, B., Ames, R.G., O’Malley, M., Chrislop, D., and Russo, J., Chronic neurological sequelae in organophosphate pesticide poisoning, Am. J. Public Health, 84, 731, 1995.
34. Yokoyama, K., Araki, S., Kaysuyutci, M., Nishihitani, M., Okumura, T., Ishimatsu, S., Takasu, N., and White, R.F. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to post-traumatic stress disorders, Arch. Environ. Health, 53, 245, 1998.
35. Ames, R., Steenland, K., Jenkins, B., Chrislop, D., and Russo, J. Chronic neurologic sequelae to cholinesterase inhibition among agriculture pesticide applicators, Arch. Environ. Health, 50, 440, 1995.
36. Stephens, R., Spurgeon, A., Calvert, I.A., Beach, J., Levy, L.S., Berry, H., and Harrington, J.M., Neuropsychological effects of long-term exposure to organophosphates in sheep dip, Lancet, 345, 1135, 1995.
37. Duffy, F.H., Burchfiel, J.L., Bartels, P.H., Gaon, M., and Sim, V.M., Long-term effects of an organophosphate upon the human encephalogram, Toxicol. Appl. Pharmacol., 47, 161, 1979.
38. National Academy of Science, Committee on Toxicology, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents. Vol. I. Anticholinesterases and Anticholinergics, prepared by Panel on Anticholinesterase Chemicals, Panel on Anticholinergic Chemicals, Committee on Toxicology, National Academy of Science, National Academy Press, Washington, DC, 1982.
39. Baskin, S.I. and Fricke, R.E., The pharmacology of p-aminopropiophenone in the detoxification of cyanide, Cardio. Drug Rev., 10(13), 358, 1992.
40. Johnson, W.D. and Becci, P., Effects of methemoglobin versus potassium cyanide intoxication, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD, Contract #DAMD17-83-C-3083, DTIC #AD B108718L.
41. Bright, J.E. and Marrs, T.C., Effect of p-aminopropiophenone (PAPP), a cyanide antidote, on cyanide given by intravenous infusion, Hum. Toxicol., 6, 133, 1987.
42. Smith, R.P., Toxic responses of the blood, in Casarett and Doull’s Toxicology: The Basic Science of Poisons (4th ed.), Amdur, M.O., Doull, J., and Klaasen, C.D., Eds., Pergamon Press, New York, 1991, chap. 8.
43. Baskin, S.I., Porton, D.W., Rockwood, G.A., Romano, J.A., Patel, H.C., Kiser R.C., Cook, C.M., and Ternay, A.L. In vitro and in vivo comparison of sulfur donors as antidotes to acute cyanide intoxication, J. Appl. Toxicol., 19, 173, 1999.
44. Dunn, M.A., Hackley, B.E., and Sidell, F.R., Pretreatment for nerve agent exposure. in Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R. and Bellamy, R.F., Eds., Office of the Surgeon General, Department of the Army, Washington, DC, 1997, chap. 6.
45. Schifflett, S.G., Stranges, S.F., Slater, T., and Jackson, M.K., Interactive effects of PB and attitude on performance, in Proceedings of the 6th Medical Chemical Defense Bioscience Review, Aberdeen Proving Ground, MD, 605, 1987.
46. Forster, E.M., Barber, J.A., Parker, F.R., Whinnery, J.E., Burton, R.R., and Bell I., Effects of pyridostigmine bromide on acceleration tolerance and performance, Aviat. Space Environ. Med., 65, 110, 1994.
47. Kolka, M.A. and Stephenson, L.A., Human temperature regulation during exercise after oral pyridostigmine administration, Aviat. Space Environ. Med., 6, 220, 1990.
48. Gall, D., The use of therapeutic mixtures in treatment of cholinesterase inhibition, Fundam. Appl. Toxicol., 1, 214, 1981.
49. Sharabi, Y., Danon, Y.L., Berkenstadt, H., Almog, S., Mimouni-Block, A., Zisman, A., Dani, S., and Atsmon, J., Survey of symptoms following intake of PB during the Persian Gulf War, Isr. J. Med. Sci., 27, 656, 1991.
50. Golomb, B., A Review of the Scientific Literature as It Pertains to Gulf War Illnesses. Vol. II. Pyridostigmine Bromide. URL http//:www.gulflink.osd.mil/library/randrep/pb_paper.
51. Lenz, D. and Cerasoli, D., Nerve agent bioscavengers: Protection with reduced behavioral deficits, J. Mil. Psychol., in press.
52. Raveh, L., Greenwald, J., Marcus, P., Papier, Y., Cohen, E., and Ashani, Y., Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity, Biochem. Pharmacol., 45, 2465, 1993.
53. Raveh, L., Grauer, E., Greenwald, J., Cohen, E., and Ashani, Y., The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase, Toxicol. Appl. Pharmacol., 145, 45, 1997.
54. Wolfe, A.D., Rush, R.S., Doctor, B.P., Koplovitz, I. and Jones, D., Acetylcholinesterase prophylaxis against organophosphate toxicity, Fundam. Appl. Toxicol., 9, 266, 1987.
55. Koplovitz, I., Romano, J.A., and Stewart, J.R., Rapid assessment of motor performance decrement following soman poisoning in mice, Drug Chem. Toxicol., 22, 221, 1987.
56. Maxwell, D.M., Brecht, K.M., Doctor, B.P., and Wolfe, A.D., Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase, J. Pharmacol. Exper. Ther. 264, 1085, 1993.
57. Brandeis, R., Raveh, L., Grunwald, J., Cohen, E., and Ashani, Y., Prevention of somaninduced cognitive deficits by pretreatment with human butyrylcholinesterase in rats, Pharmacol. Biochem. Behav., 126, 311, 1993.
58. Broomfield, C.A., Maxwell, D.M., Solana, R.P., Castro, C.A., Finger, A.V., and Lenz, D.E. Protection of butyrylcholinesterase against organophosphorus poisoning in nonhuman primates, J. Pharmacol Exp. Ther., 259, 633, 1991.
59. Wolfe, A.D., Blick, D.W., Murphy, M.R., Miller, S.A., Gentry, M.K., Hartgraves, S.L., and Doctor, B.P., Use of cholinesterase as pretreatment drugs for the protection of rhesus monkeys against soman toxicity, Toxicol. Appl. Pharmacol., 117, 189, 1992.
60. Stokes, J.W. and Banderet, L.E., Psychological aspects of chemical defense and warfare, Mil. Psychol., 9, 395, 1997.
61. DiGiovanni, C., Domestic terrorism with chemical or biological agents: Psychiatric aspects, Am. J. Psychiatry, 156, 1500, 1999.
62. Hyams, K.C., Wignall, F.S., and Roswell, R., War syndromes and their evaluation: From the U.S. Civilian War to the Persian Gulf War, Ann. Intern. Med., 125, 398, 1996.
63. Ursano, R.J., Combat stress in the chemical and biological warfare environment, Aviat. Space Environ. Med., 59(12), 1123, 1988.
64. Arenburg, B. and Hiss, J., Suffocation from misuse of gas masks during the Gulf War, Br. Med. J., 3018, 92, 1992.
65. Bleich, A., Dycian, A., Koslowsky, M., Solomon, Z., and Wiener, M., Psychic implications of missile attacks on a civilian population: Israeli lessons from the Persian Gulf War, JAMA, 268(5), 613, 1992.
66. Yokoyama, K., Araki, S., Murata, K., Nishihitani, M., Okumura, T., Ishimatsu, S., and Takasu, N., Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning, J. Physiol., 92, 317, 1998.
67. Sidell, F.R., Nerve agents, in Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R. and Bellamy, R.F., Eds., Office of the Surgeon General, Department of the Army, Washington, DC, 1997, chap. 5.
68. Ohtomi, S., Medical experience with sarin casualties in Japan, in 1996 Medical Defense Bioscience Review Proceedings, King, J.M., Ed., U.S. Army Medical Research Institute of Chemical Defense Aberdeen Proving Ground, MD, AD A 321842. Vol 3, 1182, 1996.